H&H Pharmaceuticals, LLC v. Chattem Chemicals, Inc., et al
| H&H PHARMACEUTICALS, LLC |
| CHATTEM CHEMICALS, INC. and SUN PHARMACEUTICALS INDUSTRIES, INC. |
| 23-16179 |
| September 13, 2023 |
| U.S. Court of Appeals, Ninth Circuit |
| Ovrpmnts & Enforcement of Judgments |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 10, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Filed (ECF) Streamlined request for extension of time to file Opening Brief by Appellant H&H Pharmaceuticals, LLC. New requested due date is 12/13/2023. [12822684] [23-16179] (Smith, Abraham) [Entered: 11/10/2023 01:30 PM] |
| Filing 9 MEDIATION ORDER FILED: The dial-in assessment conference scheduled for October 10, 2023, is canceled. By 10/10/2023, counsel to email Circuit Mediator regarding settlement potential. Include Ninth Circuit case name and number in subject line. This communication will be kept confidential, if requested, and should not be filed with the court. The existing briefing schedule remains in effect. SEE ORDER FOR DETAILS. [12805869] (BLS) [Entered: 10/06/2023 09:09 AM] |
| Filing 8 MEDIATION CONFERENCE SCHEDULED - DIAL-IN Assessment Conference, 10/10/2023, 9:00 a.m. PACIFIC Time. The briefing schedule previously set by the court remains in effect. See order for instructions and details. [12800253] (BLS) [Entered: 09/27/2023 04:35 PM] |
| Filing 7 The Mediation Questionnaire for this case was filed on 09/20/2023. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[12796247]. [23-16179] (AD) [Entered: 09/21/2023 06:44 AM] |
| Filing 6 Filed (ECF) Appellant H&H Pharmaceuticals, LLC Mediation Questionnaire. Date of service: 09/20/2023. [12796228] [23-16179] (Smith, Abraham) [Entered: 09/20/2023 09:53 PM] |
| Filing 5 Added Attorney(s) Ethan William Weber for party(s) Appellee Chattem Chemicals, Inc., in case 23-16179. [12795900] (BJK) [Entered: 09/20/2023 02:08 PM] |
| Filing 4 Added Attorney(s) Benjamin C. Sasse for party(s) Appellee Chattem Chemicals, Inc., in case 23-16179. [12795895] (BJK) [Entered: 09/20/2023 02:06 PM] |
| Filing 3 Filed (ECF) notice of appearance of Ethan W. Weber (Tucker Ellis LLP, 950 Main Avenue, Suite 1100, Cleveland, OH 44113) for Appellees Chattem Chemicals, Inc. and Sun Pharmaceuticals Industries, Inc.. Date of service: 09/20/2023. (Party was previously proceeding with counsel.) [12795432] [23-16179] (Weber, Ethan) [Entered: 09/20/2023 07:08 AM] |
| Filing 2 Filed (ECF) notice of appearance of Benjamin C. Sasse' (Tucker Ellis LLP, 950 Main Avenue, Suite 1100, Cleveland, OH 44113) for Appellees Chattem Chemicals, Inc. and Sun Pharmaceuticals Industries, Inc.. Date of service: 09/20/2023. (Party was previously proceeding with counsel.) [12795430] [23-16179] (Sasse, Benjamin) [Entered: 09/20/2023 07:06 AM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Appellant H&H Pharmaceuticals, LLC Mediation Questionnaire due on 09/20/2023. Appellant H&H Pharmaceuticals, LLC opening brief due 11/13/2023. Appellees Chattem Chemicals, Inc. and Sun Pharmaceuticals Industries, Inc. answering brief due 12/13/2023. Appellant's optional reply brief is due 21 days after service of the answering brief. [12791793] (JBS) [Entered: 09/13/2023 03:29 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
